Didier M Lambert Selected Research

Didier M Lambert Research Topics

Disease

6	Inflammation (Inflammations) 02/2015 - 07/2010
6	Neuroblastoma 06/2013 - 09/2007
4	Colitis 02/2015 - 08/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2015 - 06/2011
3	Neoplasms (Cancer) 03/2012 - 01/2011
3	Glioma (Gliomas) 09/2003 - 03/2003
2	Catalepsy 06/2012 - 11/2010
2	Pathologic Processes 04/2012 - 01/2006
2	Obesity 07/2010 - 02/2006
1	Melanoma (Melanoma, Malignant) 03/2012
1	Skin Neoplasms (Skin Cancer) 03/2012
1	Necrosis 03/2012
1	Experimental Melanoma 03/2012
1	Neuroinflammatory Diseases 08/2011
1	Body Weight (Weight, Body) 07/2011
1	Central Nervous System Diseases (CNS Diseases) 07/2011
1	Hypothermia 11/2010
1	Epilepsy (Aura) 06/2008
1	Allergic Contact Dermatitis 12/2007
1	Alcoholism (Alcohol Abuse) 07/2007
1	Substance-Related Disorders (Drug Abuse) 02/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2006
1	Leukemia 06/2005

Drug/Important Bio-Agent (IBA)

10	EndocannabinoidsIBA 04/2012 - 04/2003
5	anandamide (arachidonylethanolamide)IBA 04/2012 - 04/2003
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2012 - 01/2006
4	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 04/2012 - 09/2003
3	EnzymesIBA 02/2015 - 06/2005
3	palmidrolIBA 02/2015 - 01/2011
3	LigandsIBA 08/2011 - 09/2007
3	CannabinoidsIBA 11/2010 - 09/2003
2	CB2 Cannabinoid ReceptorIBA 02/2015 - 09/2013
2	amidaseIBA 02/2015 - 06/2005
2	N-acylethanolaminesIBA 02/2015 - 01/2011
2	AcidsIBA 02/2015 - 06/2005
2	EstersIBA 10/2013 - 09/2003
2	Monoacylglycerol LipasesIBA 10/2013 - 08/2011
2	HU 211 (HU 210)IBA 06/2012 - 11/2010
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2015
1	LipidsIBA 10/2013
1	ProstaglandinsIBA 10/2013
1	Biological ProductsIBA 10/2013
1	LipopolysaccharidesIBA 10/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	Proteins (Proteins, Gene)FDA Link 06/2013
1	Mesalamine (Mesalazine)FDA LinkGeneric 10/2012
1	Cannabinoid Receptor AgonistsIBA 06/2012
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 03/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2012
1	N-phenylmaleimideIBA 02/2012
1	Sulfonic AcidsIBA 08/2011
1	JZL 184IBA 08/2011
1	N- (2- hydroxy- 1- methylethyl)- 9- octadecenamideIBA 07/2011
1	Cytostatic AgentsIBA 01/2011
1	N-oleoylethanolamineIBA 01/2011
1	ColforsinIBA 01/2009
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2009
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2008
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 09/2007
1	Cysteine (L-Cysteine)FDA Link 07/2007
1	Disulfiram (Antabuse)FDA Link 07/2007
1	DisulfidesIBA 07/2007
1	Cannabinoid Receptor AntagonistsIBA 02/2006
1	Nicotine FDA Link 02/2006
1	Opiate AlkaloidsIBA 02/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	capsazepineIBA 09/2003
1	Arachidonic Acid (Vitamin F)IBA 09/2003
1	Phosphates (Orthophosphate)IBA 09/2003
1	N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA 04/2003
1	Dihydrotachysterol (AT 10)IBA 03/2003

Therapy/Procedure

1	Oral Administration 02/2015
1	Aftercare (After-Treatment) 10/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2011
1	Analgesia 11/2010
1	Skin Care 12/2007